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effective agents and dosage; and 6) integrate local resistance,
efﬁcacy and cost effectiveness. Judicious use is of utmost impor-
tance to assure retention of antibiotic susceptibility of respiratory
pathogens.
http://dx.doi.org/10.1016/j.ijid.2014.03.500
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Does guideline adherence have a positive
impact on the outcome of community-acquired
respiratory tract infection?
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Community-acquired respiratory tract infections (CA-RTIs) are
a common reason for the presentation of patients for medical care,
duringwhichanantibiotic is commonlyprescribed, and these infec-
tions are associated with considerable morbidity and/or mortality.
Clinical practice guidelines have been developed in many parts of
the world, with the aim of improving the overall quality of care
in order to achieve the best patient outcomes. However, despite
reviewing similar evidence, there arediscrepancies in the antibiotic
recommendations of guidelines from different parts of the world,
which may relate either to differences in the interpretation of the
same evidence base, or to local differences in the epidemiological
aspects of the various infections. Importantly, in order to ensure
that the guidelines are effective, there is a need to evaluate the lev-
els of adherence to the speciﬁc guideline recommendations, aswell
as to determine whether guideline adherence is associated with
improved patient outcomes. In general, studies have clearly doc-
umented that there are relatively poor levels of adherence to the
antibiotic recommendations of the various guidelines. In the case of
upper respiratory tract infections (URTIs), there tends to be overuse
of antibiotics, in general, with the prescription of a much broader
spectrum of agents than is commonly required. Furthermore, since
the overall beneﬁt of antibiotics in URTIs is relatively small, it is
usually difﬁcult to document an improvement in patient outcomes
with antibiotic adherence. The evidence in the case of lower respi-
ratory tract infections is much more clear-cut. While generally the
levels of adherence to the antibiotic recommendations also tend
to be rather low, there is evidence in sicker patients, such as those
with severe exacerbations of chronic obstructive pulmonary dis-
ease and in cases with community-acquired pneumonia, including
the elderly and critically ill patients, that adherence to the guideline
recommendations is clearly associated with improved outcomes.
Among these beneﬁts is improved patient survival, shorter times
to clinical stability, time to switch therapy, and length of hospital
stay, and also evidence of improved cost effectiveness of care. All
these issues will be addressed in the current presentation.
http://dx.doi.org/10.1016/j.ijid.2014.03.501
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Although still largely neglected and underappreciated, schisto-
somiasis is an important infectiousdiseaseof poverty. Indeed, some
800 million people are at risk of schistosomiasis and more than
200 million people are infected with blood-dwelling trematodes
of the genus Schistosoma. In 2010, the global burden of schisto-
somiasis has been estimated at 3.3 million disability-adjusted life
years, and this burden was largely concentrated on sub-Saharan
Africa. Perhaps more than any other infectious disease, schisto-
somiasis is deeply rooted in social-ecological systems and the
disease is common where poverty persists. Transmission occurs
through human-water contact patterns; hence, is governed by
social behaviour (e.g. open defecation that contaminates unpro-
tected freshwater bodies) and ecological factors (e.g. living in close
proximity to suitable freshwater bodies inhabited by intermedi-
ate host snails). The current mainstay of schistosomiasis control –
endorsed by the World Health Assembly in 2001 and reinforced
by the London Declaration in 2012 – is preventive chemotherapy.
This strategy emphasises the periodic, large-scale administra-
tion of the antischistosomal drug praziquantel to school-aged
children and other high-risk groups. While preventive chemother-
apy is the backbone of morbidity control, it fails to address the
root behavioural, ecological and social causes of schistosomiasis.
Hence, additional tools and strategies are required that should be
combined with preventive chemotherapy, readily tailored to spe-
ciﬁc social-ecological contexts and adapted over time. There is a
considerable body of historic evidence with multi-sectoral, inte-
grated intervention packages that interrupted the transmission of
schistosomiasis and achieved local elimination. Importantly, con-
temporary experiences document the impact of such integrated
control packages beyond the target disease schistosomiasis, thus
tackling other infectious diseases of poverty.
http://dx.doi.org/10.1016/j.ijid.2014.03.502
